RecruitingNCT05022420
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
Sponsor
University Hospital, Brest
Enrollment
600 participants
Start Date
Aug 19, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- biospy required for the diagnsis or follow up aged of more than 18 non opposition form
Exclusion Criteria1
- unable to consent demencia unable to fill the form and questionnaire patient Under juridical protection refusing to participate
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05022420
Related Trials
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
NCT055276521 location
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
NCT037072621 location
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
NCT056447171 location
Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients
NCT061891701 location
Risk Factors for Poor Tolerance of Ureteral Double-J Stent
NCT068151071 location